UK markets closed

Teijin Limited (TINLY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
9.650.00 (0.00%)
At close: 03:30PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close9.65
Open9.65
Bid0.00 x 0
Ask0.00 x 0
Day's range9.65 - 9.65
52-week range8.01 - 11.03
Volume82
Avg. volume240
Market cap1.929B
Beta (5Y monthly)0.34
PE ratio (TTM)N/A
EPS (TTM)-0.24
Earnings date13 May 2024
Forward dividend & yield0.19 (1.98%)
Ex-dividend date28 Sept 2023
1y target estN/A
  • GlobeNewswire

    Ascendis Pharma Announces Strategic Partnership with Teijin Limited in Japan

    – Teijin to receive exclusive license to further develop and commercialize TransCon™ hGH, TransCon™ PTH, and TransCon™ CNP in Japan – Ascendis Pharma is eligible to receive $70 million upfront, development/regulatory milestones of up to $175 million, transfer pricing, and commercial milestones – Ascendis Pharma is also eligible to receive royalties on net sales in Japan, of up to mid-20’s percent, varying by product COPENHAGEN, Denmark, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasd